Incidence, predictors, and impact on survival of left ventricular systolic dysfunction and recovery in advanced cancer patients

American Journal of Cardiology

Volumn 113, Issue 11, 2014, Pages 1893-1898

  Oliveira, Guilherme H ^a   Mukerji, Siddarth ^b   Hernandez, Adrian V ^c,d   Qattan, Marwan Y ^a   Banchs, Jose ^e   Durand, Jean Bernard ^e   Iliescu, Cezar ^e   Plana, Juan Carlos ^c   Wilson Tang, W H ^c  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d UNIVERSIDAD PERUANA DE CIENCIAS APLICADAS   (Peru)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; ANTHRACYCLINE; ANTINEOPLASTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CYCLOPHOSPHAMIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; SPIRONOLACTONE; TRASTUZUMAB; VASCULOTROPIN INHIBITOR;

ADULT; ADVANCED CANCER; AGE; AGED; ARTICLE; CANCER CENTER; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER THERAPY; CARDIOTOXICITY; COHORT ANALYSIS; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HEART LEFT ATRIUM VOLUME; HEART VOLUME; HUMAN; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; LEUKEMIA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; OBSERVATIONAL STUDY; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL;

COMBINED MODALITY THERAPY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART VENTRICLES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS; OHIO; PROGNOSIS; RECOVERY OF FUNCTION; RETROSPECTIVE STUDIES; STROKE VOLUME; SURVIVAL RATE; SYSTOLE; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 84900851846     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2014.03.018     Document Type: Article

References (21)

1. D.L. Packer, G.H. Bardy, S.J. Worley, M.S. Smith, F.R. Cobb, R.E. Coleman, J.J. Gallagher, and L.D. German Tachycardia-induced cardiomyopathy: a reversible form of left ventricular dysfunction Am J Cardiol 57 1986 563 570
2. R.N. Sachs, and P. Valensi Reversible cardiomyopathy due to thyrotoxicosis Am J Cardiol 71 1993 501
3. A.J. Larner Selenium deficiency, reversible cardiomyopathy and short-term intravenous feeding Postgrad Med J 70 1994 764 765
4. M. Barbandi, A. Cordero-Reyes, C. Orrego, G. Torre-Amione, H. Seethamraju, and J. Estep A case series of reversible acute cardiomyopathy associated with H1N1 influenza infection Methodist Debakey Cardiovasc J 8 2012 42 45
5. I.S. Wittstein, D.R. Thiemann, J.A. Lima, K.L. Baughman, S.P. Schulman, G. Gerstenblith, K.C. Wu, J.J. Rade, T.J. Bivalacqua, and H.C. Champion Neurohumoral features of myocardial stunning due to sudden emotional stress N Engl J Med 352 2005 539 548
6. J.P. Boehmer, R.C. Starling, L.T. Cooper, G. Torre-Amione, I. Wittstein, G.W. Dec, D.W. Markham, M.J. Zucker, J. Gorcsan 3rd, C. McTiernan, K. Kip, and D.M. McNamara Left ventricular assist device support and myocardial recovery in recent onset cardiomyopathy J Card Fail 18 2012 755 761
7. D.M. McNamara, R.C. Starling, L.T. Cooper, J.P. Boehmer, P.J. Mather, K.M. Janosko, J. Gorcsan 3rd, K.E. Kip, and G.W. Dec Clinical and demographic predictors of outcomes in recent onset dilated cardiomyopathy: results of the IMAC (Intervention in Myocarditis and Acute Cardiomyopathy)-2 study J Am Coll Cardiol 58 2011 1112 1118
8. S. Fazio, E.A. Palmieri, B. Ferravante, F. Bonè, B. Biondi, and L. Saccà Doxorubicin-induced cardiomyopathy treated with carvedilol Clin Cardiol 21 1998 777 779
9. S.W. Yusuf, N.A. Ilias-Khan, and J.B. Durand Chemotherapy-induced cardiomyopathy Expert Rev Cardiovasc Ther 9 2011 231 243
10. D. Cardinale, A. Colombo, G. Lamantia, N. Colombo, M. Civelli, G. De Giacomi, M. Rubino, F. Veglia, C. Fiorentini, and C.M. Cipolla Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy J Am Coll Cardiol 55 2010 213 220
11. E.T. Yeh, and C.L. Bickford Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management J Am Coll Cardiol 53 2009 2231 2247
12. P.S. Douglas, J.M. DeCara, R.B. Devereux, S. Duckworth, J.M. Gardin, W.A. Jaber, A.J. Morehead, J.K. Oh, M.H. Picard, S.D. Solomon, K. Wei, and N.J. Weissman Echocardiographic imaging in clinical trials: American Society of Echocardiography Standards for echocardiography core laboratories: endorsed by the American College of Cardiology Foundation J Am Soc Echocardiogr 22 2009 755 765
13. S.T. Reeves, K.E. Glas, H. Eltzschig, J.P. Mathew, D.S. Rubenson, G.S. Hartman, and S.K. Shernan Guidelines for performing a comprehensive epicardial echocardiography examination: recommendations of the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists J Am Soc Echocardiogr 20 2007 427 437
14. R.M. Lang, M. Bierig, R.B. Devereux, F.A. Flachskampf, E. Foster, P.A. Pellikka, M.H. Picard, M.J. Roman, J. Seward, J.S. Shanewise, S.D. Solomon, K.T. Spencer, M.S. Sutton, and W.J. Stewart Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J Am Soc Echocardiogr 18 2005 1440 1463
15. H. Dokainish, J.S. Nguyen, J. Bobek, R. Goswami, and N.M. Lakkis Assessment of the American Society of Echocardiography- European Association of Echocardiography guidelines for diastolic function in patients with depressed ejection fraction: an echocardiographic and invasive haemodynamic study Eur J Echocardiogr 12 2011 857 864
16. M. Jessup, W. Abraham, D. Casey, A. Feldman, G. Francis, T. Ganiats, M. Konstam, D. Mancini, P. Rahko, M. Silver, L. Stevenson, and C. Yancy 2009 focused update: ACCF/AHA guidelines for the diagnosis and management of heart failure in adults: a report of the american College of Cardiology Foundation/American Heart Association Task Force on Practice guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation Circulation 119 2009 1977 2016
17. S.A. Hunt, W.T. Abraham, M.H. Chin, A.M. Feldman, G.S. Francis, T.G. Ganiats, M. Jessup, M.A. Konstam, D.M. Mancini, K. Michl, J.A. Oates, P.S. Rahko, M.A. Silver, L.W. Stevenson, and C.W. Yancy 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation Circulation 119 2009 e391 e479
18. W.A. Teeter, J.T. Thibodeau, K. Rao, M.E. Brickner, K.H. Toto, L.L. Nelson, J.D. Mishkin, C.R. Ayers, J.G. Miller, P.P. Mammen, P.C. Patel, D.W. Markham, and M.H. Drazner The natural history of new-onset heart failure with a severely depressed left ventricular ejection fraction: implications for timing of implantable cardioverter-defibrillator implantation Am Heart J 164 2012 358 364
19. W.P. Abhayaratna, J.B. Seward, C.P. Appleton, P.S. Douglas, J.K. Oh, A.J. Tajik, and T.S. Tsang Left atrial size: physiologic determinants and clinical applications J Am Coll Cardiol 47 2006 2357 2363
20. G.H. Oliveira, B.W. Hardaway, A.Y. Kucheryavaya, J. Stehlik, L.B. Edwards, and D.O. Taylor Characteristics and survival of patients with chemotherapy-induced cardiomyopathy undergoing heart transplantation J Heart Lung Transpl 31 2012 805 810
21. NSCLC Meta-Analyses Collaborative Group Chemotherapy in addition to supportive care improves survival in advanced non- small-cell lung cancer: a systematic review and meta-analysis of individual patient data from 16 randomized controlled trials J Clin Oncol 26 2008 4617 4625